Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer: Clinical perspective
- 31 January 1986
- Vol. 27 (1) , 9-15
- https://doi.org/10.1016/s0090-4295(86)80004-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Optimal Testosterone Concentration for the Treatment of Prostatic CancerJournal of Urology, 1985
- Effectiveness of Castration Versus Intravenous Estrogen Therapy in Producing Rapid Endocrine Control of Metastatic Cancer of the ProstateJournal of Urology, 1985
- Des lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostateUrology, 1985
- Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostateUrology, 1985
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- Long Term Effects of Administration of a Gonadotropin Releasing Hormone Superagonist Analog in Men with Prostatic CarcinomaJournal of Clinical Endocrinology & Metabolism, 1984
- New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgensThe Prostate, 1983
- Cardiovascular Complications in the Treatment of Prostatic CarcinomaBritish Journal of Urology, 1981
- Plasma testosterone in patients receiving diethylstilbestrolUrology, 1978
- Ureteral Obstruction from Prostatic Carcinoma: Response to Endocrine and Radiation TherapyJournal of Urology, 1977